MedTrace Logo

Effects of a Standardised Saffron Extract Supplementation on Symptoms Associated With Perimenopause in Healthy Women

NCT06227858 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2026-04-17

No results posted yet for this study

Summary

The aim of the present study is to assess the effects of a normalised saffron extract supplementation, which is an extract of the flower Crocus sativus, on perimenopausal symptoms.

Conditions

  • Perimenopausal Disorder

Interventions

DIETARY_SUPPLEMENT

Safr'Inside supplement (Activ'Inside, SAS)

Dietary supplementation will be taken in addition to habitual diet of the patients

OTHER

Plcebo

Placebo capsule (matched to the experimental intervention in terms of colours and taste, without the active compounds saffron)

Sponsors & Collaborators

  • University of East Anglia

    collaborator OTHER

  • Activ'inside

    collaborator INDUSTRY

  • Liaquat University of Medical & Health Sciences

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
40 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-20
Primary Completion
2026-04-10
Completion
2026-04-10

Countries

  • Pakistan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06227858 on ClinicalTrials.gov